0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cancer Biomarkers
 1-20 of 203 Articles
JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Dirk Klingbiel, PhD; Sabine Tejpar, MD, PhD
JAMA Oncol. Published online January 14, 2016. doi:10.1001/jamaoncol.2015.5226

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Julien Taieb, MD, PhD; Aziz Zaanan, MD, PhD; Karine Le Malicot, MS; et al.
JAMA Oncol. Published online January 14, 2016. doi:10.1001/jamaoncol.2015.5225
Includes: Supplemental Content

JAMA Dermatology | 
Brief Report |  ONLINE FIRST
Mina S. Ally, MD; Katherine Ransohoff, BA; Kavita Sarin, MD, PhD; et al.
JAMA Dermatol. Published online January 13, 2016. doi:10.1001/jamadermatol.2015.5473
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Sean E. McGuire, MD, PhD
JAMA Oncol. Published online January 07, 2016. doi:10.1001/jamaoncol.2015.4952

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Joseph R. Evans, MD, PhD; Shuang G. Zhao, MD; S. Laura Chang, PhD; et al.
JAMA Oncol. Published online January 07, 2016. doi:10.1001/jamaoncol.2015.4955
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary | 
Feriyl Bhaijee, MD; Robert A. Anders, MD, PhD
JAMA Oncol. 2016;2(1):54-55. doi:10.1001/jamaoncol.2015.3782.

JAMA Oncology | 
Viewpoint | 
Aaron R. Hansen, MBBS (Hons), FRACP; Lillian L. Siu, MD
JAMA Oncol. 2016;2(1):15-16. doi:10.1001/jamaoncol.2015.4685.

JAMA Oncology | 
Editorial | 
Sylvia Adams, MD, MS
JAMA Oncol. 2016;2(1):25-27. doi:10.1001/jamaoncol.2015.3236.

JAMA Oncology | 
Editorial | 
Greg Yothers, PhD; Nan Song, PhD; Thomas J. George Jr, MD
JAMA Oncol. 2016;2(1):23-24. doi:10.1001/jamaoncol.2015.3614.

JAMA Oncology | 
Original Investigation | 
Shanwu Gao, MSc; Chabane Tibiche, MSc; Jinfeng Zou, PhD; et al.
JAMA Oncol. 2016;2(1):37-45. doi:10.1001/jamaoncol.2015.3413.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.
JAMA Oncol. 2016;2(1):29-36. doi:10.1001/jamaoncol.2015.3709.
Includes: Supplemental Content

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Jashodeep Datta, MD; Megan Fracol, MD; Matthew T. McMillan, BA; et al.
JAMA Oncol. Published online December 30, 2015. doi:10.1001/jamaoncol.2015.5482
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Adrian G. Sacher, MD; Suzanne E. Dahlberg, PhD; Jennifer Heng, BS; et al.
JAMA Oncol. Published online December 17, 2015. doi:10.1001/jamaoncol.2015.4482
Includes: Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
Jee Ye Kim, MD; Seung-il Kim, MD, PhD; Soonmyung Paik, MD
JAMA Oncol. Published online December 03, 2015. doi:10.1001/jamaoncol.2015.4343

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Michail Ignatiadis, MD, PhD; Hatem A. Azim Jr, MD, PhD; Christine Desmedt, PhD; et al.
JAMA Oncol. Published online December 03, 2015. doi:10.1001/jamaoncol.2015.4377
Includes: Supplemental Content

JAMA Surgery | 
Original Investigation |  ONLINE FIRST
Christina L. Roland, MD; Genevieve M. Boland, MD, PhD; Elizabeth G. Demicco, MD; et al.
JAMA Surg. Published online December 02, 2015. doi:10.1001/jamasurg.2015.4205
Includes: Supplemental Content

JAMA Dermatology | 
Original Investigation | 
Shirin Bajaj, BA; Stephen W. Dusza, DrPH; Michael A. Marchetti, MD; et al.
JAMA Dermatol. 2015;151(12):1338-1345. doi:10.1001/jamadermatol.2015.2231.
Includes: Supplemental Content

JAMA Dermatology | 
Editorial | 
Claus Garbe, MD
JAMA Dermatol. 2015;151(12):1291-1292. doi:10.1001/jamadermatol.2015.2236.

JAMA Oncology | 
Invited Commentary | 
Christopher J. Sweeney, MBBS
JAMA Oncol. 2015;1(9):1270-1271. doi:10.1001/jamaoncol.2015.3005.

JAMA Oncology | 
Viewpoint | 
Howard (Jack) West, MD
JAMA Oncol. 2015;1(9):1219-1220. doi:10.1001/jamaoncol.2015.2966.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Microsatellite Instability and BRAF and KRAS Mutations in Stage III Colon Cancer Requirements for Accurate Prognosis Assessment
Dirk Klingbiel, PhD; Sabine Tejpar, MD, PhD
JAMA Oncology
Original Investigation  | 
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab A Post Hoc Analysis of the PETACC-8 Trial
Julien Taieb, MD, PhD; Aziz Zaanan, MD, PhD; Karine Le Malicot, MS; et al.
JAMA Dermatology
Brief Report  | 
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
Mina S. Ally, MD; Katherine Ransohoff, BA; Kavita Sarin, MD, PhD; et al.
JAMA Oncology
Invited Commentary  | 
DNA Damage and Repair Pathway Profiles as Biomarkers in High-Risk Prostate Cancer
Sean E. McGuire, MD, PhD